Declaration of Ethics The Authors have adhered to the Principles of Veter- inary Medical Ethics of the AVMA.
Conflict of Interest
Dr. Cywes-Bentley has licensing and potential roy- alty income for monoclonal antibody to PNAG from
Alopexx Pharmaceuticals, LLC. Dr. Gerald Pier has licensing income, equity shares, and potential roy- alty income from Alopexx Vaccines, LLC for vaccines to PNAG. Sarah Anthony and Patrick Sutter are owner and employee, respectively. Dr. Daniel Vlock is the CEO of Alopexx Enterprises.